Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma

被引:2
|
作者
Hamilton, Mark P. [1 ,2 ,3 ]
Miklos, David B. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat & Cellular Therapy, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA
关键词
CAR T-cell; Large B-cell lymphoma; Aggressive lymphoma; CAR T-cell toxicity; CAR T-cell resistance; Review; CD19; NON-HODGKIN-LYMPHOMA; AXICABTAGENE CILOLEUCEL; DOSE-ESCALATION; OUTCOMES; RESPONSES; MULTICENTER; REMISSIONS; LEUKEMIA; IMPACT; TRIAL;
D O I
10.1016/j.hoc.2023.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1053 / 1075
页数:23
相关论文
共 50 条
  • [31] Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma
    Ernst, Moritz
    Oeser, Annika
    Besiroglu, Burcu
    Caro-Valenzuela, Julia
    Aziz, Mohamed Abd El
    Monsef, Ina
    Borchmann, Peter
    Estcourt, Lise J.
    Skoetz, Nicole
    Goldkuhle, Marius
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [32] Late adverse events in patients with aggressive B-cell lymphoma after CD19-targeted chimeric antigen receptor T-cell therapy
    Camacho Arteaga, Lina
    Leguizamo Martinez, Lina Maria
    Filippi Arriaga, Francesca
    Iacoboni Garcia-Calvo, Gloria
    Alonso Martinez, Carla
    Vidal Guitart, Xavier
    Lopez Corral, Lucia
    Perez Lopez, Estefania
    Kwon, Mi
    Bailen Almorox, Rebeca
    Hernani Morales, Rafael
    Guerreiro, Manuel
    Maiquez Asuero, Maria Pilar
    Barba Sunol, Pere
    Agusti Escasany, Antonia
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 22 - 22
  • [33] Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
    Manzar, Gohar S.
    Pinnix, Chelsea C.
    Dudzinski, Stephanie O.
    Marqueen, Kathryn E.
    Cha, Elaine E.
    Nasr, Lewis F.
    Yoder, Alison K.
    Rooney, Michael K.
    Strati, Paolo
    Ahmed, Sairah
    Nze, Chijioke
    Nair, Ranjit
    Fayad, Luis E.
    Wang, Michael
    Nastoupil, Loretta J.
    Westin, Jason R.
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Gunther, Jillian R.
    Dabaja, Bouthaina S.
    Wu, Susan Y.
    Fang, Penny Q.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [34] Frequency of secondary T-cell lymphoma in chimeric antigen receptor T-cell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen T-cell therapy
    Brieghel, Christian
    Petersen, Soren L.
    Brown, Peter de N.
    Niemann, Carsten U.
    HAEMATOLOGICA, 2025, 110 (03) : 768 - 771
  • [35] Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas
    Johnson, P. Connor
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2561 - 2567
  • [36] CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN ADULT PATIENTS WITH B-CELL LYMPHOPROLIFERATIVE DISEASES
    Gavrilina, O. A.
    Galstyan, G. M.
    Shchekina, A. E.
    Kotova, E. S.
    Maschan, M. A.
    Troitskaya, V. V.
    Koroleva, D. A.
    Zvonkov, E. E.
    Fidarova, Z. T.
    Vasilyeva, V. A.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (01): : 8 - 28
  • [37] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [38] The promise of CAR T-cell therapy in aggressive B-cell lymphoma
    Nair, Ranjit
    Neelapu, Sattva S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (03) : 293 - 298
  • [39] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
    Seyedin, Roxanna
    Snider, Julia T.
    Rajagopalan, Krithika
    Wade, Sally W.
    Gergis, Usama
    FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
  • [40] Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma
    Lutfi, Forat
    Holtzman, Noa
    Siglin, Jonathan
    Bukhari, Ali
    Mustafa Ali, Moaath
    Kim, Dong
    Sanchez-Petitto, Gabriela
    Gottlieb, David
    Ruehle, Kathleen
    Hutnick, Elizabeth
    Gahres, Natalie
    Hankey, Kim
    Lee, Seung
    Kocoglu, Mehmet
    Yared, Jean
    Hardy, Nancy
    Rapoport, Aaron
    Dahiya, Saurabh
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 212 - 216